PODD
Insulet·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 6
Bearish signal 0
Consensus Rating "Strong Buy"
Ample Liquidity
High Gross Profit Margin
High Cash/net Profit Ratio
Revenue Beats Expectation
EPS Beats Expectation
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About PODD
Insulet Corporation
An innovative medical device company that develops wireless, handheld insulin infusion systems for people with insulin-dependent diabetes
Healthcare Equipment and Supplies
--
05/15/2007
NASDAQ Stock Exchange
3,900
12-31
Common stock
100 Nagog Park, Acton, Massachusetts 01720
--
Insulet Corporation is a Delaware corporation established in 2000. The Company is principally engaged in the development, manufacture and sale of its proprietary continuous insulin delivery system for patients with insulin-dependent diabetes mellitus. The Omnipod platform includes: Omnipod 5 Automatic Insulin Delivery System, Omnipod DASH Insulin Management System, Omnipod Insulin Management System and the latest innovative product Omnipod GOTM, licensed by the US Food and Drug Administration in 2023. The company also manufactures Pods for Amgen for use in Neulasta Onpro kits, a delivery system for Amgen's Neulasta that helps reduce the risk of infection after intensive chemotherapy.
Earnings Call
Q1/2025
Estimate EPS0.79
Actual EPS1.02
Estimate Revenue543.30M
Actual Revenue569.00M
Insulet's 2025 Q1 Earnings Call: Key Contradictions in Type 2 Market Growth and Sales Strategy
May 19,2025 11:21
Earnings Decrypt
Earnings Decrypt
Q2/2025
Estimate EPS0.92
Actual EPS1.17
Estimate Revenue612.26M
Actual Revenue649.10M
Insulet's Q2 2025: Navigating Contradictions in U.S. Growth, Type 2 Diabetes Expectations, and Global Strategy
Aug 07,2025 11:24
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
PODD has released its 2025 Q3 earnings. EPS was reported at 1.24, versus the expected 1.14, beating expectations. The chart below visualizes how PODD has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
PODD has released its 2025 Q3 earnings report, with revenue of 706.30M, reflecting a YoY change of 29.86%, and net profit of 87.60M, showing a YoY change of 13.03%. The Sankey diagram below clearly presents PODD's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
